ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Bial and Eisai receive positive opinion for Zebinix to treat focal onset epilepsy
March 30, 2017Bial and Eisai have announced the receipt of a positive opinion for Zebinix (eslicarbazepine acetate) from the European Medicine Agency's Committee for Medicinal Products for Human Use (CHMP) to treat adults with newly-diagnosed focal onset epilepsy.
Pharma Sources Insight January 2025
